Umoja Biopharma | $100,000,000 | (Jan 21, 2025)
Fundment | $55,157,175 | (Jan 21, 2025)
r4 | $1,000,000 | (Jan 21, 2025)
Certified by Founder
Lodge
Genialis
start up
United States
- Boston, MA
- 30/03/2023
- Series A
- $13,000,000
Genialis is a computational precision medicines company unraveling complex biology to find new ways to address disease. Our mission is to deliver benefit and hope to patients and their families. Our method is to leverage biomedical data and advanced analytics to help pharma companies develop more effective drugs with higher probability of clinical success, and diagnostics companies to deploy tests that lead to better treatment decisions.
- Industry Biotechnology
- Website https://www.genialis.com/
- LinkedIn https://www.linkedin.com/company/genialis/
Related People
Rafael RosengartenFounder
United States -
McClellanville, South Carolina
Leads Genialis’ effort to integrate and mine vast and diverse sources of biomedical knowledge to realize the promise of precision medicine and therapeutic discovery.
IntusCare | $11,500,000 | (Jan 21, 2025)
Alteva Technologies | $1,760,526 | (Jan 21, 2025)
ecoplanet | $16,571,680 | (Jan 21, 2025)
StepChange.work | $4,000,000 | (Jan 21, 2025)
Sereact | $25,894,660 | (Jan 21, 2025)
Men In Blazers Media Network | $150,000,000 | (Jan 21, 2025)
Pipe17 | $15,500,000 | (Jan 17, 2025)
Coram AI | $13,800,000 | (Jan 17, 2025)
Quantifind | $22,000,000 | (Jan 17, 2025)